Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue
Submit an article Journal homepage
44
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China

Wenyu Ye1 Real World Analytics, Eli Lilly and Company, Indianapolis, IN, USA
,
William Montgomery2 Global Patient Outcomes and Real World Evidence, Eli Lilly Australia Pty Ltd, West Ryde, AustraliaCorrespondence[email protected]
,
Zbigniew Kadziola3 Real World Analytics Capabilities, Eli Lilly GmbH, Vienna, Austria
,
Li Liu4 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai Branch, People’s Republic of China
,
Haibo Xue4 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai Branch, People’s Republic of China
,
Michael D Stensland5 Agile Outcomes Research, Inc., Rochester, MN, USA
&
Tamas Treuer6 Neuroscience Research, Eli Lilly and Company, Budapest, Hungary
 show all
Pages 869-878 | Published online: 16 May 2014

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.